The IFN-γ production in adoptively transferred tumor-specific CD8+ T cells was boosted by BRAFi treatment, which can be well explained by the favorable inflammatory TME that enables the migration of activated DC to the draining LN. The gene discussed is CD8A; the disease is neoplasm.